Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Angiology. 2015 Sep 30;67(7):657–663. doi: 10.1177/0003319715609013

Table 3.

Univariable Predictors of All-cause and Cardiovascular Mortality*

All-cause Death Cardiovascular Death
Age 1.04 (1.02–1.06, p<0.001) 1.03 (1.00 – 1.06, p = 0.02)
Gender 1.50 (0.90 – 2.50, p=0.12) 1.60 (0.79 – 3.26, p=0.19)
Height 1.00 (0.98 – 1.03, p=0.92) 0.98 (0.95 – 1.02, p=0.29)
Body Mass Index 1.04 (1.00 – 1.09, p=0.03) 1.07 (1.02 – 1.12, p=0.01)
Any tobacco history 0.78 (0.49 – 1.28, p=0.34) 1.00 (0.52 – 1.92, p=1.0)
Current tobacco 0.66 (0.37 – 1.19, p=0.17) 0.70 (0.32 – 1.54, p=0.38)
Obesity (BMI > 30) 1.35 (0.82 – 2.22, p=0.24) 1.38 (0.71 – 2.70, p=0.34)
Hyperlipidemia 0.89 (0.53 – 1.48, p=0.65) 0.95 (0.47 – 1.92, p=0.88)
Hypertension 0.42 (0.13 – 1.33, p=0.14) 0.33 (0.08 – 1.37, p=0.13)
Diabetes 1.88 (1.17 – 3.03, p<0.01) 1.87 (0.97 – 3.60, p=0.06)
Congestive Heart Failure 2.61 (1.54 – 4.44, p<0.001) 5.37 (2.78 – 10.36, p<0.001)
Cardiomyopathy 2.20 (0.80 – 6.05, p=0.13) 3.14 (0.96 –10.24, p=0.05)
Chronic Obstructive Pulmonary Disease 1.07 (0.56 – 2.04, p=0.84) 1.12 (0.47 – 2.70, p=0.80)
Prior Stroke/Transient Ischemic Attack 1.56 (0.85 – 2.86, p=0.15) 2.20 (1.04 – 4.68, p=0.04)
Atrial Fibrillation 5.39 (2.31 – 12.61, p<0.001) 6.63 (2.31 – 19.00, p<0.001)
Coronary Artery Disease 2.01 (1.19 – 3.39, p<0.01) 2.47 (1.16 – 5.26, p=0.02)
End-Stage Renal Disease 1.49 (0.78 – 2.84, p=0.23) 0.98 (0.35 – 2.77, p=0.97)
Prior Myocardial Infarction 1.39 (0.74 – 2.60, p=0.30) 1.79 (0.81 – 3.92, p=0.15)
Prior Coronary Artery Bypass 1.44 (0.85 – 2.44, p=0.18) 1.84 (0.92 – 3.67, p=0.09)
Known Peripheral Vascular Disease 1.07 (0.56 – 2.04, p=0.85) 1.47 (0.70 – 3.06, p=0.31)
Baseline Hemoglobin 0.81 (0.71 – 0.92, p<0.001) 0.73 (0.61 – 0.88, p<0.001)
Baseline Creatinine 1.29 (1.04 – 1.59, p=0.02) 1.23 (0.91 – 1.68, p=0.42)
*

Shown are estimated Hazard Ratios (HR) and associated 95% Confidence intervals (CI).